GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study
- PMID: 21784738
- DOI: 10.1093/humrep/der220
GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study
Abstract
Background: It is now well established that a GnRH agonist (GnRHa) ovulation trigger completely prevents ovarian hyperstimulation syndrome. However, early studies, using conventional luteal support, showed inferior clinical results following a GnRHa trigger compared with a conventional hCG trigger in normal responder IVF patients. We here present a novel approach for luteal support after a GnRHa trigger. METHODS Normal responder patients who failed at least one previous IVF attempt, during which a conventional hCG trigger was used, were consecutively enrolled in the study. A GnRH antagonist-based ovarian stimulation protocol was used in combination with a GnRHa trigger (Triptorelin 0.2 mg). The luteal phase was supported with a total of two boluses of 1500 IU hCG: on the day of oocyte retrieval and 4 days later. Neither progesterone nor estradiol was administered for luteal support.
Results: The mean age was 33.8 years. The mean (± SD) numbers of oocytes and fertilized oocytes were 6.7 (± 2.5) and 3.6 (± 1.7), respectively. All 15 patients had embryo transfers and 11 patients conceived. On the day of pregnancy test (14 days after retrieval), the mean serum E(2) and progesterone levels were 6607 (± 3789) and 182 (± 50) nmol/l, respectively. Of the pregnancies, seven are ongoing, while four ended as miscarriages.
Conclusions: These preliminary results suggest that two boluses of 1500 IU hCG revert the luteolysis after a GnRHa trigger in the normo-responder patient. Importantly, no additional luteal support is needed. The novel concept combines the potential advantages of a physiological dual trigger (LH and FSH) with a simple, patient friendly, luteal support.
Similar articles
-
Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.Hum Reprod. 2015 Oct;30(10):2387-95. doi: 10.1093/humrep/dev184. Epub 2015 Jul 23. Hum Reprod. 2015. PMID: 26209535 Clinical Trial.
-
Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.Eur J Obstet Gynecol Reprod Biol. 2006 May 1;126(1):87-92. doi: 10.1016/j.ejogrb.2005.11.013. Epub 2005 Dec 22. Eur J Obstet Gynecol Reprod Biol. 2006. PMID: 16377065 Clinical Trial.
-
1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study.Fertil Steril. 2010 Feb;93(3):847-54. doi: 10.1016/j.fertnstert.2008.12.042. Epub 2009 Feb 6. Fertil Steril. 2010. PMID: 19200959 Clinical Trial.
-
GnRHa to trigger final oocyte maturation: a time to reconsider.Hum Reprod. 2009 Oct;24(10):2389-94. doi: 10.1093/humrep/dep246. Epub 2009 Jul 16. Hum Reprod. 2009. PMID: 19608565 Review.
-
[Onset and maintenance of the luteal phase with GnRH agonists or hCG in cycles under GnRH antagonists].J Gynecol Obstet Biol Reprod (Paris). 2004 Oct;33(6 Pt 2):3S24-6. J Gynecol Obstet Biol Reprod (Paris). 2004. PMID: 15643682 Review. French.
Cited by
-
Luteal phase support for assisted reproduction cycles.Cochrane Database Syst Rev. 2015 Jul 7;2015(7):CD009154. doi: 10.1002/14651858.CD009154.pub3. Cochrane Database Syst Rev. 2015. PMID: 26148507 Free PMC article. Review.
-
Individualized luteal phase support after fresh embryo transfer: unanswered questions, a review.Reprod Health. 2022 Jan 22;19(1):19. doi: 10.1186/s12978-021-01320-7. Reprod Health. 2022. PMID: 35065655 Free PMC article. Review.
-
GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF/ICSI Cycles-A Systematic PRISMA Review and Meta-analysis.Front Endocrinol (Lausanne). 2017 Jun 7;8:116. doi: 10.3389/fendo.2017.00116. eCollection 2017. Front Endocrinol (Lausanne). 2017. PMID: 28638367 Free PMC article. Review.
-
Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment.Endocr Rev. 2018 Oct 1;39(5):593-628. doi: 10.1210/er.2017-00236. Endocr Rev. 2018. PMID: 29982525 Free PMC article. Review.
-
Contribution to More Patient-Friendly ART Treatment: Efficacy of Continuous Low-Dose GnRH Agonist as the Only Luteal Support-Results of a Prospective, Randomized, Comparative Study.Int J Endocrinol. 2015;2015:727569. doi: 10.1155/2015/727569. Epub 2015 Apr 5. Int J Endocrinol. 2015. PMID: 25945092 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources